For the 15th consecutive year, Global Competition Review (GCR) has recognized Davies as an “Elite” Canadian firm – the highest category in the jurisdiction – in its annual guide to the world’s top competition practices.

Among our recent work across the full spectrum of competition and foreign investment review law, we have advised:

• Shaw Communications Inc. in a lengthy trial before the Competition Tribunal concerning the company’s contested $26 billion merger with Rogers Communications Inc.;
• S&P Global Inc. on Canadian regulatory matters in its US$44-billion all-stock merger with IHS Markit;
• Alexion Pharmaceuticals Inc. as Canadian counsel in its US$39-billion acquisition by AstraZeneca plc;
• WESCO International, Inc. as Canadian competition counsel in its transformative US$4.5-billion acquisition of Anixter International Inc., creating the premier electrical, communications and utility distribution and supply chain solutions company;
• TRATON SE as Canadian competition counsel in its US$3.7-billion acquisition of Navistar International Corporation;
• Medline Industries, Inc. on Canadian regulatory matters in an investment by a private equity consortium comprising funds managed by Blackstone, Carlyle and Hellman & Friedman; and
• SK hynix Inc. and SK hynix America Inc. in class action proceedings alleging price fixing of dynamic access random memory in the Québec Superior Court and the Federal Court, including defeating certification in both jurisdictions.

Using independently compiled research, the GCR 100 provides a qualitative analysis of the law firms doing the most important competition and antitrust work around the world.